Balancing Innovation and Lifecycle Strategy in the Era of the IRA

Balancing Innovation and Lifecycle Strategy in the Era of the IRA

In the third part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data Science, explains the strategies that manufacturers should adopt to balance investment in innovation with lifecycle management.

Webinar | IRA Medicare Part D Redesign

Two additional sessions will be offered: August 18 – 12:00 – 12:45 (UTC +8:00) – Asia August 18 – 12:00 – 12:45 CET – Europe/Berlin Medicare Part D is undergoing its most significant transformation in decades largely driven by the Inflation Reduction Act (IRA). What does this mean for pharmaceutical manufacturers? Join us for an engaging discussion with Max Hunt… Source